BridgeBio Oncology Therapeutics (BBOT) targets KRAS and PI3Ka malignancies with next-generation small molecule therapeutics, ...
Flow Space on MSN
Update: Is there really about to be a breast cancer vaccine?
Sound more like science fiction than actual science? Then, brace yourself because there are, at least, 15 breast cancer ...
Black TNBC Patients Lack Equitable Access to PARP Inhibitors, Flatiron Health Real-World Study Shows
Black patients were less likely to receive PARP inhibitors, despite having BRCA1/2 testing and positivity rates comparable to White patients, and were at higher risk of death.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback